LWM
AGN

Liberty Wealth Management’s Allergan plc AGN Stock Holding History

Liberty Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,797
Closed -$495K – 1021
2020
Q1 		$495K Sell
2,797
-50
-2% -$9.41K 0.43% 43
2019
Q4 		$544K Buy
2,847
+2,585
+987% +$466K 0.43% 41
2019
Q3 		$44K Buy
262
+5
+2% +$815 0.04% 250
2019
Q2 		$43K Buy
257
+67
+35% +$9.28K 0.04% 274
2019
Q1 		$27K Buy
190
+99
+109% +$14.4K 0.02% 303
2018
Q4 		$12K Buy
+91
New +$14.9K 0.01% 407

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Liberty Wealth Management's AGN Position: Q2 2020 in Review

Liberty Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,797 shares — an estimated $495K sold.

Liberty Wealth Management first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $544K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Liberty Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Liberty Wealth Management sold 2,797 Allergan plc shares in Q2 2020, an estimated $495K.
  • Liberty Wealth Management first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Liberty Wealth Management's Allergan plc position peaked at $544K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Liberty Wealth Management's 13F filing for Q2 2020, filed 4 Aug 2020.